LOW AND HIGH RESPONDERS TO PHARMACOLOGICAL DOSES OF BETA-CAROTENE - PROPORTION IN THE POPULATION, MECHANISMS INVOLVED AND CONSEQUENCES ON BETA-CAROTENE METABOLISM
P. Borel et al., LOW AND HIGH RESPONDERS TO PHARMACOLOGICAL DOSES OF BETA-CAROTENE - PROPORTION IN THE POPULATION, MECHANISMS INVOLVED AND CONSEQUENCES ON BETA-CAROTENE METABOLISM, Journal of lipid research, 39(11), 1998, pp. 2250-2260
The aim of this study was to assess the interindividual variability of
chylomicron. beta-carotene response to a pharmacological load of beta
-carotene in the population, to identify the mechanisms responsible fo
r this variability, and to evaluate its consequences on beta-carotene
status and metabolism. The variability, as estimated by the 3-h chylom
icron if-carotene response to 120 mg beta-carotene in 79 healthy male
volunteers, was high (CV = 61%), but it was unimodal and all the subje
cts had detectable chylomicron beta-carotene, In 16 subjects randomly
selected among the 79, the interindividual variability of the triglyce
ride-adjusted chylomicron (beta-carotene + retinyl palmitate) response
(0-12.5 h area under the curve) was high (CV = 54%), suggesting that
there is a high interindividual variability in the efficiency of intes
tinal absorption of beta-carotene. The chylomicron beta-carotene respo
nse was correlated (r = 0.50, P < 0.05) with the chylomicron triglycer
ide response. The beta-carotene status, as assessed by beta-carotene c
oncentration in buccal mucosal cells, was correlated (r = 0.73, P < 0.
05) with the triglyceride-adjusted chylomicron beta-carotene response,
i.e., with the ability to respond to beta-carotene. The triglyceride-
adjusted chylomicron retinyl-palmitate response was correlated (r = 0.
55, P < 0.05) with the triglyceride-adjusted chylomicron p-carotene re
sponse. Plasma all-trans retinoic acid slightly, but significantly, in
creased (+40%) 3 h after the beta-carotene load, bat this increase was
not related to the triglyceride-adjusted beta-carotene response.jlr Z
n conclusion, the ability to respond to beta-carotene is highly variab
le, but there is probably a very small proportion of true non-responde
rs to pharmacological doses of beta-carotene in the healthy population
. This variability is apparently mainly due to interindividual differe
nces in the efficiency of intestinal absorption of beta-carotene and i
n chylomicron metabolism. The ability to respond to beta-carotene can
affect the beta-carotene status and the provitamin A activity of beta-
carotene, but it has apparently no effect on the amount of retinoic ac
id appearing in the plasma after the ingestion of a pharmacological do
se of beta-carotene.